Global Bioenergies announces the successful completion of new toxicology studies on its first cosmetic ingredient, naturally occurring isododecane, which will now be available for use in the broad dermocosmetic and hair care markets.
In October 2020, a first phase of toxicology studies opened the door to the use of naturally occurring isododecane, produced by Global Bioenergies, in the makeup segment.
A new toxicological assessment conducted in cooperation with an independent consulting firm now complements the first study from 2020. It validates the use of Global Bioenergies' renewable isododecane in dermocosmetics and hair care products, areas where isododecane is used in much higher volumes than in make-up. This new step will allow Global Bioenergies to enrich its proposition to the leaders of the Beauty and Care sector, in order to increase the overall naturalness of the cosmetics field.
From 2022, Global Bioenergies will increase its production volumes with the Pomacle unit, which will serve the make-up market and sample the dermocosmetic and hair care fields.
At the end of 2024, a larger production plant, whose project is currently under study, would come into operation in order to fully serve these fields of dermocosmetics and hair care.
Marc Delcourt, CEO and co-founder of Global Bioenergies, states: "We are pursuing our strategy of conquest in stages: horizon 1 materialized in 2021 with the launch of our own brand, Last . At the beginning of 2022, horizon 2 will materialize with the start-up of our Pomacle unit to serve the niche market of high-value but limited-volume make-up ingredients. As we prepare for the larger dermocosmetics and hair care markets, we are already anticipating our horizon 3, which will see the light of day in 2024."
